Overview

Pharmacokinetics and Safety of HCP1303 and Co-administration of HGP1201, HIP1402 in Healthy Male Volunteers

Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
To investigate the pharmacokinetic properties and safety after administration of HCP1303 and co-administration of HGP1201, HIP1402 in healthy male volunteers
Phase:
Phase 1
Details
Lead Sponsor:
Hanmi Pharmaceutical Company Limited